tiprankstipranks
pc:expre

ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies is a biotechnology company specializing in the development of innovative vaccines and immunotherapies. Utilizing its clinically validated ExpreS2 platform, the company focuses on advancing a pipeline that includes a lead breast cancer vaccine currently in Phase I trials. Based in Hørsholm, Denmark, ExpreS2ion aims to deliver cutting-edge solutions to address unmet medical needs in the field of immunotherapy.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$12M
Total Amount Raised$12M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$12M
Latest Funding Amount$12M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Investment
$11.80M

Investors

Investor Name
Funding Round
Investment
Investment
Investment
Investment

Related News and Analysis